l0015na001655y

6
C000007331 SRL LIMITED SPLZD (OPD) - (IDA) FORTIS HOSPITAL,SECTOR - 62, NEAR HALDIRAM FACTORY, NOIDA NOIDA 201301 UTTAR PRADESH INDIA CLIENT CODE : CLIENT'S NAME AND ADDRESS : Cert. No. M-0164 SRL LIMITED. C/O FORTIS HOSPITAL, B-22, SECTOR-62 NOIDA, 201301 UTTAR PRADESH, INDIA Tel : 0120-2403338 Email : - PATIENT NAME : AMALKUMAR ROY PATIENT ID : FHL5.118568 ACCESSION NO : 0015NA001655 AGE : 53 Years SEX : Male DATE OF BIRTH : 03/01/1961 DRAWN : 05/01/2014 09:39 RECEIVED : 05/01/2014 10:04 REPORTED : 05/01/2014 16:32 REFERRING DOCTOR : DR. Vinod Kumar Vasishtha CLIENT PATIENT ID : UHID:118568 IPID: OPD-OPD FRONT OFFICE CLINICAL INFORMATION : Final Results Biological Reference Range Units Test Report Status LIVER & KIDNEY PROFILE ASPARTATE AMINOTRANSFERASE, SERUM ASPARTATE AMINOTRANSFERASE (AST/SGOT) 24 15 - 37 U/L METHOD : UV WITH P5P ALANINE AMINOTRANSFERASE, SERUM ALANINE AMINOTRANSFERASE (ALT/SGPT) 58 30 - 65 U/L METHOD : UV WITH P5P ALKALINE PHOSPHATASE, SERUM ALKALINE PHOSPHATASE 101 50 - 136 U/L METHOD : PNP - AMP BUFFER * BILIRUBIN (TOTAL, DIRECT, INDIRECT), SERUM BILIRUBIN, TOTAL 0.90 0.00 - 1.00 mg/dL METHOD : SULPH ACID DPL/CAFF-BENZ BILIRUBIN, DIRECT 0.21 0.00 - 0.30 mg/dL METHOD : SULPH ACID DPL/CAFF-BENZ BILIRUBIN, INDIRECT 0.69 0.1 - 1.0 mg/dL GAMMA GLUTAMYL TRANSFERASE, SERUM GAMMA GLUTAMYL TRANSFERASE (GGT) 43 5 - 85 U/L METHOD : GLUTAMYL-3-CO-4NOANILIDE LACTATE DEHYDROGENASE, SERUM LACTATE DEHYDROGENASE 185 85 - 227 U/L METHOD : LACTATE -PYRUVATE UV ALBUMIN+GLOBULIN+A/G RATIO, SERUM ALBUMIN 4.3 3.4 - 5.0 g/dL GLOBULIN 3.0 2.0 - 4.1 g/dL ALBUMIN/GLOBULIN RATIO 1.4 1.0 - 2.1 RATIO TOTAL PROTEIN, SERUM TOTAL PROTEIN 7.3 6.4 - 8.2 g/dL METHOD : BIURET, END POINT BLOOD UREA NITROGEN, SERUM BLOOD UREA NITROGEN 10 6 - 20 mg/dL METHOD : PHOSPHOMOLYBDATE UV FORMATION CREATININE, SERUM CREATININE 1.1 0.9 - 1.3 mg/dL METHOD : ALKALINE PICRATE-KINATIC * BUN/CREAT RATIO BUN/CREAT RATIO 9.09 5.00 - 15.00 Page 1 Of 6

Upload: amit621988

Post on 21-Oct-2015

11 views

Category:

Documents


5 download

DESCRIPTION

Sample lab report

TRANSCRIPT

Page 1: L0015NA001655Y

C000007331

SRL LIMITED SPLZD (OPD) - (IDA)FORTIS HOSPITAL,SECTOR - 62, NEAR HALDIRAM FACTORY,NOIDANOIDA 201301UTTAR PRADESH INDIA

CLIENT CODE :

CLIENT'S NAME AND ADDRESS :

Cert. No. M-0164

SRL LIMITED.C/O FORTIS HOSPITAL, B-22, SECTOR-62NOIDA, 201301UTTAR PRADESH, INDIATel : 0120-2403338Email : -

PATIENT NAME : AMALKUMAR ROY PATIENT ID : FHL5.118568

ACCESSION NO : 0015NA001655 AGE : 53 Years SEX : Male DATE OF BIRTH : 03/01/1961

DRAWN : 05/01/2014 09:39 RECEIVED : 05/01/2014 10:04 REPORTED : 05/01/2014 16:32

REFERRING DOCTOR : DR. Vinod Kumar Vasishtha CLIENT PATIENT ID : UHID:118568

IPID: OPD-OPD FRONT OFFICE

CLINICAL INFORMATION :

Final Results Biological Reference Range UnitsTest Report Status

LIVER & KIDNEY PROFILE

ASPARTATE AMINOTRANSFERASE, SERUM

ASPARTATE AMINOTRANSFERASE (AST/SGOT) 24 15 - 37 U/LMETHOD : UV WITH P5P

ALANINE AMINOTRANSFERASE, SERUM

ALANINE AMINOTRANSFERASE (ALT/SGPT) 58 30 - 65 U/LMETHOD : UV WITH P5P

ALKALINE PHOSPHATASE, SERUM

ALKALINE PHOSPHATASE 101 50 - 136 U/LMETHOD : PNP - AMP BUFFER

* BILIRUBIN (TOTAL, DIRECT, INDIRECT), SERUMBILIRUBIN, TOTAL 0.90 0.00 - 1.00 mg/dL

METHOD : SULPH ACID DPL/CAFF-BENZ

BILIRUBIN, DIRECT 0.21 0.00 - 0.30 mg/dLMETHOD : SULPH ACID DPL/CAFF-BENZ

BILIRUBIN, INDIRECT 0.69 0.1 - 1.0 mg/dL

GAMMA GLUTAMYL TRANSFERASE, SERUM

GAMMA GLUTAMYL TRANSFERASE (GGT) 43 5 - 85 U/LMETHOD : GLUTAMYL-3-CO-4NOANILIDE

LACTATE DEHYDROGENASE, SERUM

LACTATE DEHYDROGENASE 185 85 - 227 U/LMETHOD : LACTATE -PYRUVATE UV

ALBUMIN+GLOBULIN+A/G RATIO, SERUM

ALBUMIN 4.3 3.4 - 5.0 g/dL

GLOBULIN 3.0 2.0 - 4.1 g/dL

ALBUMIN/GLOBULIN RATIO 1.4 1.0 - 2.1 RATIO

TOTAL PROTEIN, SERUM

TOTAL PROTEIN 7.3 6.4 - 8.2 g/dLMETHOD : BIURET, END POINT

BLOOD UREA NITROGEN, SERUM

BLOOD UREA NITROGEN 10 6 - 20 mg/dLMETHOD : PHOSPHOMOLYBDATE UV FORMATION

CREATININE, SERUM

CREATININE 1.1 0.9 - 1.3 mg/dLMETHOD : ALKALINE PICRATE-KINATIC

* BUN/CREAT RATIO

BUN/CREAT RATIO 9.09 5.00 - 15.00

Page 1 Of 6

Page 2: L0015NA001655Y

C000007331

SRL LIMITED SPLZD (OPD) - (IDA)FORTIS HOSPITAL,SECTOR - 62, NEAR HALDIRAM FACTORY,NOIDANOIDA 201301UTTAR PRADESH INDIA

CLIENT CODE :

CLIENT'S NAME AND ADDRESS :

Cert. No. M-0164

SRL LIMITED.C/O FORTIS HOSPITAL, B-22, SECTOR-62NOIDA, 201301UTTAR PRADESH, INDIATel : 0120-2403338Email : -

PATIENT NAME : AMALKUMAR ROY PATIENT ID : FHL5.118568

ACCESSION NO : 0015NA001655 AGE : 53 Years SEX : Male DATE OF BIRTH : 03/01/1961

DRAWN : 05/01/2014 09:39 RECEIVED : 05/01/2014 10:04 REPORTED : 05/01/2014 16:32

REFERRING DOCTOR : DR. Vinod Kumar Vasishtha CLIENT PATIENT ID : UHID:118568

IPID: OPD-OPD FRONT OFFICE

CLINICAL INFORMATION :

Final Results Biological Reference Range UnitsTest Report Status

ELECTROLYTES (NA/K/CL), SERUM

SODIUM 136 136 - 145 mmol/LMETHOD : INTEGRATED MULTISENSOR TECHNOLOGY

POTASSIUM 4.30 3.50 - 5.10 mmol/LMETHOD : INTEGRATED MULTISENSOR TECHNOLOGY

CHLORIDE 100 98 - 107 mmol/LMETHOD : INTEGRATED MULTISENSOR TECHNOLOGY

URIC ACID, SERUM

URIC ACID 5.4 3.5 - 7.2 mg/dLMETHOD : URICASE/CATALASE UV

URINALYSIS

COLOR PALE YELLOWMETHOD : MANUAL

APPEARANCE CLEARMETHOD : MANUAL

PH 6.0 4.7 - 7.5METHOD : REFLECTANCE SPECTROPHOTOMETRY

SPECIFIC GRAVITY 1.005 1.003 - 1.035METHOD : REFLECTANCE SPECTROPHOTOMETRY

GLUCOSE NOT DETECTED NOT DETECTEDMETHOD : REFLECTANCE SPECTROPHOTOMETRY

PROTEIN NOT DETECTED NOT DETECTEDMETHOD : REFLECTANCE SPECTROPHOTOMETRY

KETONES NOT DETECTED NOT DETECTEDMETHOD : REFLECTANCE SPECTROPHOTOMETRY

BLOOD NOT DETECTED NOT DETECTEDMETHOD : REFLECTANCE SPECTROPHOTOMETRY

BILIRUBIN NOT DETECTED NOT DETECTEDMETHOD : REFLECTANCE SPECTROPHOTOMETRY

UROBILINOGEN NORMAL NORMALMETHOD : REFLECTANCE SPECTROPHOTOMETRY

NITRITE NOT DETECTED NOT DETECTEDMETHOD : REFLECTANCE SPECTROPHOTOMETRY

WBC 1-2 0-5 /HPFMETHOD : MICROSCOPY

EPITHELIAL CELLS 0-1 0-5 /HPFMETHOD : MICROSCOPY

RED BLOOD CELLS NOT DETECTED NOT DETECTED /HPFMETHOD : MICROSCOPY

Page 2 Of 6

Page 3: L0015NA001655Y

C000007331

SRL LIMITED SPLZD (OPD) - (IDA)FORTIS HOSPITAL,SECTOR - 62, NEAR HALDIRAM FACTORY,NOIDANOIDA 201301UTTAR PRADESH INDIA

CLIENT CODE :

CLIENT'S NAME AND ADDRESS :

Cert. No. M-0164

SRL LIMITED.C/O FORTIS HOSPITAL, B-22, SECTOR-62NOIDA, 201301UTTAR PRADESH, INDIATel : 0120-2403338Email : -

PATIENT NAME : AMALKUMAR ROY PATIENT ID : FHL5.118568

ACCESSION NO : 0015NA001655 AGE : 53 Years SEX : Male DATE OF BIRTH : 03/01/1961

DRAWN : 05/01/2014 09:39 RECEIVED : 05/01/2014 10:04 REPORTED : 05/01/2014 16:32

REFERRING DOCTOR : DR. Vinod Kumar Vasishtha CLIENT PATIENT ID : UHID:118568

IPID: OPD-OPD FRONT OFFICE

CLINICAL INFORMATION :

Final Results Biological Reference RangeTest Report Status

CASTS NOT DETECTEDNOT DETECTEDMETHOD : MICROSCOPY

CRYSTALS NOT DETECTEDNOT DETECTEDMETHOD : MICROSCOPY

BACTERIA NOT DETECTED NOT DETECTEDMETHOD : MICROSCOPY

REMARKS MICROSCOPIC EXAMINATION DONE ON CENTRIFUGED URINE.METHOD : MANUAL

HAEMATOLOGY

COMPLETE BLOOD COUNT, EDTA WHOLE BLOOD/SMEARCOMPLETE BLOOD COUNT

RED BLOOD CELL COUNT 4.60 4.5 - 5.5 mil/µLMETHOD : ELECTRONIC IMPEDANCE

HEMOGLOBIN 14.1 13.0 - 17.0 g/dLMETHOD : SPECTROPHOTOMETRY

HEMATOCRIT 41.0 40 - 50 %METHOD : CALCULATED PARAMETER

MEAN CORPUSCULAR VOL 89.0 83.0 - 101.0 fLMETHOD : CALCULATED PARAMETER

MEAN CORPUSCULAR HGB. 30.7 27.0 - 32.0 pgMETHOD : CALCULATED PARAMETER

MEAN CORPUSCULAR HEMOGLOBINCONCENTRATION

34.5 31.5 - 34.5 g/dL

METHOD : CALCULATED PARAMETER

RED CELL DISTRIBUTION WIDTH 11.4 11.6 - 14.0 %Low

METHOD : CALCULATED PARAMETER

PLATELET COUNT 230 150 - 410 thou/µLMETHOD : ELECTRONIC IMPEDANCE

MEAN PLATELET VOLUME 9.8 6.8 - 10.9 fLMETHOD : CALCULATED PARAMETER

WHITE BLOOD CELL COUNT 8.4 4.0 - 10.0 thou/µLMETHOD : ELECTRONIC IMPEDANCE

WBC DIFFERENTIAL COUNT

SEGMENTED NEUTROPHILS 62 40 - 80 %METHOD : VCS TECHNOLOGY

EOSINOPHILS 02 1 - 6 %METHOD : VCS TECHNOLOGY

Page 3 Of 6

Page 4: L0015NA001655Y

C000007331

SRL LIMITED SPLZD (OPD) - (IDA)FORTIS HOSPITAL,SECTOR - 62, NEAR HALDIRAM FACTORY,NOIDANOIDA 201301UTTAR PRADESH INDIA

CLIENT CODE :

CLIENT'S NAME AND ADDRESS :

Cert. No. M-0164

SRL LIMITED.C/O FORTIS HOSPITAL, B-22, SECTOR-62NOIDA, 201301UTTAR PRADESH, INDIATel : 0120-2403338Email : -

PATIENT NAME : AMALKUMAR ROY PATIENT ID : FHL5.118568

ACCESSION NO : 0015NA001655 AGE : 53 Years SEX : Male DATE OF BIRTH : 03/01/1961

DRAWN : 05/01/2014 09:39 RECEIVED : 05/01/2014 10:04 REPORTED : 05/01/2014 16:32

REFERRING DOCTOR : DR. Vinod Kumar Vasishtha CLIENT PATIENT ID : UHID:118568

IPID: OPD-OPD FRONT OFFICE

CLINICAL INFORMATION :

Final Results Biological Reference RangeTest Report Status

LYMPHOCYTES 26 20 - 40 %METHOD : VCS TECHNOLOGY

MONOCYTES 10 2 - 10 %METHOD : VCS TECHNOLOGY

BASOPHILS 00 < 1 - 2 %METHOD : VCS TECHNOLOGY

COAGULATION

PROTHROMBIN TIME, PLASMA

PROTHROMBIN TIME (PT) 13.8 11.4 - 13.7 SECONDSHigh

METHOD : OPTO MECHANICAL CLOTTING TIME

INTERNATIONAL NORMALIZED RATIO (INR) 1.05 0.00 - 1.40 RATIOMETHOD : CALCULATED PARAMETER

MEAN NORMAL PT 13.2 SECONDSMETHOD : OPTO MECHANICAL CLOTTING TIME

BIO CHEMISTRY

GLUCOSE, FASTING, PLASMA / URINE

GLUCOSE, FASTING, PLASMA 99 74 - 99 mg/dLMETHOD : HEXOKINASE

GLUCOSE, POST-PRANDIAL, PLASMA/URINE

GLUCOSE, POST-PRANDIAL, PLASMA 89 74 - 140 mg/dLMETHOD : HEXOKINASE

Comments

Causes of Low Post Prandial Blood SugarThe causes of low blood sugar that occurs following a meal have been divided traditionally into(1)Alimentary(2)Functional and(3)that in diabetics and those with impaired glucose tolerance

Alimentary Hypoglycemia usually, but not necessarily , occurs in those patients who have had gastrointestinal surgery. Accelerated absorption of aglucose load leads to marked post - prandial hyperglycemia with a corresponding exaggerated insulin release thus resulting in hypoglycaemia Theensuing hypoglycemia typically occurs from one and one half to three hours after eating. This pattern of glucose intolerance and a history ofgastrointestinal surgery are suggestive of the diagnosis.

Functional Hypoglycemia is quite common in adults; it may be characterized by abnormally low plasma glucose and symptoms of light headedness,shakiness, diaphoresis, weakness, fatigue occuring with the modest withholding of food. Complaints suggestive of this syndrome commonly are seenin those who have emotional problems.

Post Prandial Hypoglycaemia in diabetics: Patients who are diabetics or who have impaired glucose tolerance also may experience reactivehypoglycemia. In these patients, hypoglycemia occurs later than in the group with the alimentary disorder, and insulin response is delayed andexaggerated.

Page 4 Of 6

Page 5: L0015NA001655Y

C000007331

SRL LIMITED SPLZD (OPD) - (IDA)FORTIS HOSPITAL,SECTOR - 62, NEAR HALDIRAM FACTORY,NOIDANOIDA 201301UTTAR PRADESH INDIA

CLIENT CODE :

CLIENT'S NAME AND ADDRESS :

Cert. No. M-0164

SRL LIMITED.C/O FORTIS HOSPITAL, B-22, SECTOR-62NOIDA, 201301UTTAR PRADESH, INDIATel : 0120-2403338Email : -

PATIENT NAME : AMALKUMAR ROY PATIENT ID : FHL5.118568

ACCESSION NO : 0015NA001655 AGE : 53 Years SEX : Male DATE OF BIRTH : 03/01/1961

DRAWN : 05/01/2014 09:39 RECEIVED : 05/01/2014 10:04 REPORTED : 05/01/2014 16:32

REFERRING DOCTOR : DR. Vinod Kumar Vasishtha CLIENT PATIENT ID : UHID:118568

IPID: OPD-OPD FRONT OFFICE

CLINICAL INFORMATION :

Final Results Biological Reference RangeTest Report Status

* CORONARY RISK PROFILE (LIPID PROFILE), SERUMCHOLESTEROL 103 < 200 Desirable

200 - 239 Borderline High>/= 240 High

mg/dL

METHOD : CHOLESTROL OXIDASE

TRIGLYCERIDES 110 < 150 Normal150 - 199 Borderline High200 - 499 High>/=500 Very High

mg/dL

METHOD : LIPASE / GLUCOSE DEHYDROGENASE

CHOLESTEROL HDL 33 < 40 Low>/=60 High

mg/dLLow

METHOD : PHOSPHOTUNGSTATE/MAGNESIUM

DIRECT LDL CHOLESTEROL 52 < 100 Optimal100 - 129 Near or above optimal130 - 159 Borderline High160 - 189 High>/= 190 Very High

mg/dL

METHOD : DIRECT MEASURE

CHOL/HDL RATIO 3.1 3.3 - 4.4 Low Risk4.5 - 7.0 Average Risk7.1 - 11.0 Moderate Risk> 11.0 High Risk

Low

LDL/HDL RATIO 1.6 0.5 - 3.0 Desirable/Low Risk3.1 - 6.0 Borderline/Moderate Risk>6.0 High Risk

VERY LOW DENSITY LIPOPROTEIN 22.0 </= 30.0 mg/dL

Test Method(s)GLUCOSE, FASTING, PLASMA / URINE-

ADA 2012 guidelines for adults as follows:Pre-diabetics: 100 - 125 mg/dLDiabetic: > or = 126 mg/dL

(Ref: Tietz 4th Edition & ADA 2012 Guidelines)

ENDOCRINOLOGY

THYROID PANEL II, SERUM

FREE TRIIODOTHYRONINE (FT3), SERUM

FREE TRIIODOTHYRONINE (FT3) 2.71 2.0 - 4.4 pg/mL

FREE THYROXINE (FT4), SERUM

FREE THYROXINE (FT4) 0.82 0.93 - 1.70 ng/dLLow

METHOD : ECLIA

* TSH 3RD GENERATION ULTRA( TSH3 - UL)

Page 5 Of 6

Page 6: L0015NA001655Y

C000007331

SRL LIMITED SPLZD (OPD) - (IDA)FORTIS HOSPITAL,SECTOR - 62, NEAR HALDIRAM FACTORY,NOIDANOIDA 201301UTTAR PRADESH INDIA

CLIENT CODE :

CLIENT'S NAME AND ADDRESS :

Cert. No. M-0164

SRL LIMITED.C/O FORTIS HOSPITAL, B-22, SECTOR-62NOIDA, 201301UTTAR PRADESH, INDIATel : 0120-2403338Email : -

PATIENT NAME : AMALKUMAR ROY PATIENT ID : FHL5.118568

ACCESSION NO : 0015NA001655 AGE : 53 Years SEX : Male DATE OF BIRTH : 03/01/1961

DRAWN : 05/01/2014 09:39 RECEIVED : 05/01/2014 10:04 REPORTED : 05/01/2014 16:32

REFERRING DOCTOR : DR. Vinod Kumar Vasishtha CLIENT PATIENT ID : UHID:118568

IPID: OPD-OPD FRONT OFFICE

CLINICAL INFORMATION :

Final Results Biological Reference RangeTest Report Status

TSH 3RD GENERATION 6.920 0.27 - 4.20 µIU/mLHigh

Comments

NOTE:- S. TPC VALUES RECHECKED.

Test Method(s)FREE TRIIODOTHYRONINE (FT3), SERUM-The guidelines for age related reference ranges for FT3.---------------------------------------------------------------------------------------------------------Cord Blood 1.5 - 3.9 pg/mLChildren 2.1 - 4.4 pg/mLPregnancy 2.0 - 3.8 pg/mL---------------------------------------------------------------------------------------------------------FREE THYROXINE (FT4), SERUM-The guidlines for age related reference ranges for FT4.---------------------------------------------------------------------------------------------------------New Born (1-4 days) 2.2 - 5.3 ng/dLChildren 0.8- 2.7 ng/dL

Pregnancy1st Trimester 0.7- 2.0 ng/dL2nd & 3rd Trimester 0.5 - 1.6 ng/dL---------------------------------------------------------------------------------------------------------TSH 3RD GENERATION ULTRA( TSH3 - UL)-

**End Of Report**Please visit www.srlworld.com for related Test Information for this accession

TEST MARKED WITH '*' ARE OUTSIDE THE ACCREDITED SCOPE OF THE LABORATORY.

Dr. Neena VermaSenior Pathologist

Dr. Abhishant Pandey, MDPathologist

Dr. Sonia VijConsultant Pathologist

Dr. Noopur GuptaPathologist

Page 6 Of 6